Document Detail

PL-11 Transfusion issues in cancer patients.
MedLine Citation:
PMID:  22682136     Owner:  NLM     Status:  In-Data-Review    
Allogeneic blood transfusion (ABT) therapy plays a major role in the case of patients with cancer. Packed red blood cells (PRBC) are given for increased oxygen-carrying capacity, platelets concentrates (PC) and fresh frozen plasma (FFP) for the cessation and prevention of bleeding due to thrombocytopenia and other defects of hemostasis associated with neoplasia. All these blood components can induce complications and/or adverse reactions in cancer patients including transfusion-associated graft versus host disease (TA-GVHD), transfusion transmitted diseases, alloimmunization to blood cell antigens, pulmonary decompensation, immunomodulation. Therefore, specific modifications such as leukocyte-reduction and irradiation of the blood components to be transfused in cancer patients should be introduced to reduce the risk of these complications. Patients undergoing hematopoietic progenitor cell (HPC) transplantation are a unique group and present complex concerns related to transfusion, including major and minor ABO incompatibility and chimeric blood cells. Therefore, transfusion for patients undergoing treatment with cellular therapies requires careful blood component selection. The process of HPC infusion itself carries many risks including DMSO toxicity and hemolytic reactions. In all areas of transfusion therapy, new advances such as pathogen inactivation and synthetic alternatives to blood components should help to increase the safety and tolerance of transfusion in cancer patients.
Augusto B Federici; Chiara Vanelli; Luisa Arrigoni
Related Documents :
9548776 - Computational fluid dynamics model for predicting flow of viscous fluids in a large fer...
25216806 - Hematological changes and cytogenotoxicity in the tilapia oreochromis niloticus caused ...
18962976 - Investigation and analytical application of the sulphide-hypobromite chemiluminescence ...
19023466 - Enabling a microfluidic immunoassay for the developing world by integration of on-card ...
16112936 - The smartcanula: a new tool for remote access perfusion in limited access cardiac surgery.
23043376 - Do hemodialysis adequacy data reflect reality?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Thrombosis research     Volume:  129 Suppl 1     ISSN:  1879-2472     ISO Abbreviation:  Thromb. Res.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-06-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S60-5     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Hematology and Transfusion Medicine, L. Sacco University Hospital and Department of Internal Medicine, University of Milan, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  PL-01 Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Next Document:  PL-12 Acquired hemophilia in malignancy.